Yanbing Ding

Yanbing Ding possesses extensive experience in medicinal chemistry, currently serving as Research Fellow II at 上海睿智化学研究有限公司 since November 2008, where oversight of multiple programs led to the delivery of three pre-clinical candidates within a two-year timeframe. Prior roles include Senior Research Scientist at Neuromed, where leadership of a chemistry team resulted in the identification of novel calcium channel blockers, including the phase II clinical candidate MK6721. As a Research Scientist at Forbes Medi-Tech Inc., contributions advanced a cholesterol absorption inhibitor to phase II trials. Further early career experience includes research positions at the Department of Chemistry at UBC and Shenyang Medical College, alongside a foundational role as Project Leader at Shenyang Research Institute of Chemical Industry, where significant developments in herbicides and insecticides were achieved. Yanbing Ding holds Ph.D. degrees in Organic Chemistry from Lanzhou University.